SCHEMBL20076009

SCHEMBL20076009

Cc1nc2[nH]c(-c3ccc(F)cc3)cc(=O)n2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 4/20 0.45
MAPT P10636 4/20 0.45
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
HPGD P15428 3/20 0.45
HSD17B10 Q99714 3/20 0.45
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
NPY5R Q15761 1/20 0.40
TP53 P04637 3/20 0.39
RAD51 Q06609 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CTSV O60911 1/20 0.38
CTSL P07711 1/20 0.38
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20076032 0.86 NPC1 (0.45) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL20075849 0.86 ALDH1A1 (0.51) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL15660543 0.84 KDM4E (0.46) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL20076013 0.78 PIK3C3 (0.37) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL20076038 0.78 ADORA2A (0.47) ALDH1A1HPGDHSD17B10ADORA2AADORA1
SCHEMBL20076034 0.77 MEN1 (0.48) NPC1RAB9AMEN1KMT2AGAA
SCHEMBL15661030 0.77 CDC7 (0.46)
SCHEMBL17106451 0.77 TSHR (0.41) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL17106448 0.76 HAVCR2 (0.34) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL13778113 0.76 ACHE (0.44) KDM4EMAPTADORA2AADORA1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200048259-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-02-13 US claimed
US-20200048259-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-02-13 US disclosed
US-20200048259-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-02-13 US disclosed
WO-2018071282-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048259-A1 KDM5 INHIBITORS KDM5A, KDM5B, KDM5C ALDH1A1 1410/4885KDM4E 11/4885MAPT 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.